Candida albicans pathogenicity mechanisms.
Mayer FL, Wilson D, Hube B.
Virulence. 2013 Feb 15;4(2):119-28. doi: 10.4161/viru.22913. Epub 2013 Jan 9.
Looking into Candida albicans infection, host response, and antifungal strategies.
Wang Y.
Virulence. 2015;6(4):307-8. doi: 10.1080/21505594.2014.1000752. Epub 2015 Jan 15.
Biofilm of Candida albicans: formation, regulation and resistance.
Pereira R, Dos Santos Fontenelle RO, de Brito EHS, de Morais SM.
J Appl Microbiol. 2021 Jul;131(1):11-22. doi: 10.1111/jam.14949. Epub 2020 Dec 9.
Candida albicans and Candida glabrata: global priority pathogens.
Katsipoulaki M, Stappers MHT, Malavia-Jones D, Brunke S, Hube B, Gow NAR.
Microbiol Mol Biol Rev. 2024 Jun 27;88(2):e0002123. doi: 10.1128/mmbr.00021-23. Epub 2024 Jun 4.
Vaginal Candida albicans infections: host-pathogen-microbiome interactions.
Valentine M, Wilson D, Gresnigt MS, Hube B.
FEMS Microbiol Rev. 2025 Jan 14;49:fuaf013. doi: 10.1093/femsre/fuaf013.
Candida albicans Promotes Oral Cancer via IL-17A/IL-17RA-Macrophage Axis.
Wang X, Wu S, Wu W, Zhang W, Li L, Liu Q, Yan Z.
mBio. 2023 Jun 27;14(3):e0044723. doi: 10.1128/mbio.00447-23. Epub 2023 Apr 17.
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management.
Shahabudin S, Azmi NS, Lani MN, Mukhtar M, Hossain MS.
Mycoses. 2024 Jun;67(6):e13753. doi: 10.1111/myc.13753.
Candida albicans: the current status regarding vaginal infections.
Faustino M, Ferreira CMH, Pereira AM, Carvalho AP.
Appl Microbiol Biotechnol. 2025 Apr 10;109(1):91. doi: 10.1007/s00253-025-13478-2.
Commensalism and pathogenesis of Candida albicans at the mucosal interface.
Schille TB, Sprague JL, Naglik JR, Brunke S, Hube B.
Nat Rev Microbiol. 2025 Aug;23(8):525-540. doi: 10.1038/s41579-025-01174-x. Epub 2025 Apr 17.
Infection-associated genes of Candida albicans.
Hube B.
Future Microbiol. 2006 Aug;1(2):209-18. doi: 10.2217/17460913.1.2.209.
